Rite Aid and Heritage Provider Network last month announced a new agreement to bring the Rite Aid Health Alliance program to HPN's chronic and polychronic patients in Southern California.
In an effort to show investors that its able to deliver strong earnings growth, drug maker Allergan will be laying off workers and discontinuing some of its drug research, according to the Wall Street Journal.
ScriptPro and TCGRx announced that the companies will be exclusive partners in a distribution and co-marketing agreement that allows ScriptPro to bring TCGRx adherence packaging technologies to retail pharmacies throughout the United States.
The Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), a long-acting opioid analgesic.
Onco360, an independent oncology pharmacy and clinical support services company, announced that it has been selected to be part of the highly limited specialty pharmacy network of Zydelig tablets.
Walgreens today announced that Kermit Crawford, president of Pharmacy, Health and Wellness, will retire after 31 years in a variety of advancing roles with the company to take on new opportunities
Generics supplier Camber Pharmaceuticals added two new executives to its team this week, bringing on Kirk Hessels as marketing director and Amanda Rebnicky as its sales operations director.
The first batch of vaccines for the upcoming flu season is on its way to pharmacies, hospitals and doctors offices.
Health on the National Mall, co-sponsored by Cardinal Health and the National Community Pharmacists Association, showcased the expanding role pharmacists are playing in improving patient care.
The Food and Drug Administration on Wednesday announced approval for Zydelig (idelalisib) to treat patients with chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic lymphoma.